A re-assessment	1
the consequences	20
delayed transplantation of olfactory lamina propria following	40
delayed transplantation	40
olfactory lamina propria following	67
spinal cord transection in rats Oswald Steward a ,	111
spinal cord transection	111
rats Oswald Steward a ,	138
rats Oswald Steward	138
a	159
Kelli Sharp a	164
Kelli Sharp	164
a	176
Gowri Selvan a	179
Gowri Selvan	179
a	192
Anthony Hadden a	195
Anthony Hadden	195
a	210
Maura Hofstadter a	213
Maura Hofstadter	213
a	230
Edmund Au b	233
Jane Roskams b a Reeve-Irvine Research Center	246
Jane Roskams	246
a Reeve-Irvine Research Center	261
University of California at Irvine School of Medicine	293
University	293
California at Irvine School of Medicine	307
California	307
Irvine School of Medicine	321
Irvine School	321
Medicine	338
Departments of Anatomy and Neurobiology , Neurobiology and Behavior	348
Departments	348
Anatomy and Neurobiology , Neurobiology and Behavior	363
Neurosurgery	420
1105 Gillespie Neuroscience Research Facility	434
1105	434
Gillespie Neuroscience Research Facility	439
Irvine	481
CA 92697-4292	489
USA b Department of Zoology	504
USA b Department	504
Zoology	524
University of British Columbia , Vancouver , BC	533
University	533
British Columbia , Vancouver , BC	547
Canada V6T 1Z4 Abstract	580
This study	605
part	619
the NIH `` Facilities	627
Research-Spinal Cord Injury	650
contract	679
independent replication of published studies	699
independent replication	699
published studies	726
We	745
a study	757
delayed transplantation	780
olfactory lamina propria -LRB- OLP -RRB-	807
olfactory lamina propria	807
OLP	833
the site of a complete spinal cord transection	843
the site	843
a complete spinal cord transection	855
significant improvement	897
hindlimb motor function	924
axon regeneration	960
Adult female rats	979
complete spinal cord transections	1006
T10	1043
Thirty days post-injury	1048
pieces of OLP , which contains olfactory ensheathing cells -LRB- OECs -RRB-	1073
pieces of OLP , which contains olfactory ensheathing cells	1073
pieces	1073
OLP , which contains olfactory ensheathing cells	1083
OLP	1083
olfactory ensheathing cells	1103
OECs	1132
respiratory lamina propria -LRB- RLP -RRB- , which should not contain OECs	1142
respiratory lamina propria	1142
RLP	1170
OECs	1201
the transection site	1224
Hindlimb motor function	1246
the BBB scale	1287
day 1 post-injury	1306
10 weeks following transplantation	1332
10 weeks	1332
transplantation	1351
axonal regeneration	1378
the transection site	1405
Fluorogold	1427
the distal segment	1456
the distribution of 5HT-containing axons	1480
the distribution	1480
5HT-containing axons	1500
immunostaining	1540
BBB analyses	1556
no significant recovery	1578
OLP transplantation and no significant differences	1608
OLP transplantation	1608
no significant differences	1632
OLP vs. RLP transplant groups	1667
OLP	1667
RLP transplant groups	1675
Fluorogold injections into caudal segments	1698
Fluorogold injections	1698
caudal segments	1725
retrograde labeling in any animals	1757
retrograde labeling	1757
any animals	1780
Immunostaining for 5HT	1793
Immunostaining	1793
5HT	1812
a few 5HT-labeled axons	1830
both RLP and OLP transplants	1868
a few 5HT-labeled axons	1901
sections	1941
the injury	1960
2 animals	1974
OLP transplants and 1 animal that received RLP transplants	1998
OLP transplants	1998
1 animal that received RLP transplants	2018
1 animal	2018
RLP transplants	2041
Our results	2058
OLP transplants	2094
regeneration	2124
some circumstances	2143
the effect	2163
the hostile setting created by a complete transection paradigm	2215
the hostile setting	2215
a complete transection paradigm	2246
Introduction The failure	2280
axonal regeneration following injury to the central nervous system	2308
axonal regeneration	2308
injury to the central nervous system	2338
injury	2338
the central nervous system	2348
a number of factors	2398
a number	2398
factors	2410
the presence	2434
a tissue environment	2450
the lesion site that is extremely hostile to growing axons	2474
the lesion site	2474
growing axons	2519
the presence	2538
various inhibitory boundaries associated with the glial scar	2554
various inhibitory boundaries	2554
the glial scar	2600
-LRB- 3 -RRB- the presence of inhibitory molecules in myelin including Nogo	2616
the presence	2620
inhibitory molecules in myelin including Nogo	2636
inhibitory molecules	2636
myelin including Nogo	2660
myelin	2660
Nogo	2677
related ligands	2686
the `` Nogo receptor ''	2721
-LRB- 4 -RRB- lack of an adequate growth response by mature neurons	2742
lack	2746
an adequate growth response by mature neurons	2754
an adequate growth response	2754
mature neurons	2785
5	2806
lack of adequate trophic support	2809
lack	2809
adequate trophic support	2817
There	2843
numerous recent reports	2853
strategies	2888
these negative factors	2924
axon regeneration	2964
example	2987
numerous studies	2996
the potential of transplants	3027
the potential	3027
transplants	3044
the gap	3066
the lesion site	3077
embryonic tissue transplants	3104
Kawaguchi	3134
et al. , 2004 ; Kunkel-Bagden and Bregman , 1990	3144
et al.	3144
2004 ; Kunkel-Bagden and Bregman	3152
2004	3152
Kunkel-Bagden and Bregman	3158
1990	3185
peripheral nerve bridges	3192
Cheng et al. , 1996 ; David and Aguayo , 1981 ; Richardson et al. , 1984	3218
Cheng	3218
et al. , 1996 ; David and Aguayo , 1981 ; Richardson et al. , 1984	3224
et al. , 1996	3224
et al.	3224
1996	3232
David and Aguayo , 1981	3238
David and Aguayo	3238
1981	3256
Richardson et al. , 1984	3262
Richardson	3262
et al. , 1984	3273
et al.	3273
1984	3281
artificial scaffolds	3292
Bakshi et al. , 2004 ; Patist et al. , 2004 ; Tsai et al. , 2004	3314
Bakshi	3314
et al. , 2004 ; Patist et al. , 2004 ; Tsai et al. , 2004	3321
et al. , 2004	3321
et al.	3321
2004	3329
Patist et al. , 2004	3335
Patist	3335
et al. , 2004	3342
et al.	3342
2004	3350
Tsai et al. , 2004	3356
Tsai	3356
et al. , 2004	3361
et al.	3361
2004	3369
There	3376
numerous studies	3397
the therapeutic potential	3417
cellular transplants	3446
various types	3470
Schwann cells	3494
Kamada et al. , 2005 ; Meijs et al. , 2004 ; Paino and Bunge , 1991	3509
Kamada	3509
et al. , 2005 ; Meijs et al. , 2004 ; Paino and Bunge , 1991	3516
et al. , 2005	3516
et al.	3516
2005	3524
Meijs et al. , 2004	3530
Meijs	3530
et al. , 2004	3536
et al.	3536
2004	3544
Paino and Bunge , 1991	3550
Paino and Bunge	3550
1991	3567
olfactory ensheathing cells	3574
Cao	3603
et al. , 2004	3607
et al.	3607
2004	3615
Chuah et al. , 2004	3621
Chuah	3621
et al. , 2004	3627
et al.	3627
2004	3635
Kato et al. , 2000	3641
Kato	3641
et al. , 2000	3646
et al.	3646
2000	3654
Li et al. , 1997 , 1998	3660
Li	3660
et al. , 1997 , 1998	3663
et al.	3663
1997	3671
1998	3677
Lu et al. , 2001	3683
Lu	3683
et al. , 2001	3686
et al.	3686
2001	3694
Ramer et al. , 2004	3700
Ramer	3700
et al. , 2004	3706
et al.	3706
2004	3714
Ramon-Cueto et al. , 2000	3720
Ramon-Cueto	3720
et al. , 2000	3732
et al.	3732
2000	3740
Shen et al. , 2004	3746
Shen	3746
et al. , 2004	3751
et al.	3751
2004	3759
macrophages -LRB- Bomstein et al. , 2003 -RRB-	3766
macrophages	3766
Bomstein	3779
et al. , 2003	3788
et al.	3788
2003	3796
stem cells	3803
various sorts -LRB- Iwanami et al. , 2005 ; McDonald et al. , 1999 -RRB-	3817
various sorts	3817
Iwanami	3832
et al. , 2005 ; McDonald et al. , 1999	3840
et al.	3840
2005 ; McDonald et al.	3848
2005	3848
McDonald et al.	3854
McDonald	3854
et al.	3863
1999	3871
various combinations	3882
transplants and growth factors	3906
Iannotti	3938
et al. , 2003	3947
et al.	3947
2003	3955
a recent review	3966
transplantation strategies	3985
Bunge and Pearse -LRB- 2003 -RRB-	4017
Bunge and Pearse	4017
2003	4035
There	4042
numerous studies	4063
axon regeneration	4098
administering growth factors	4135
Dolbeare and Houle , 2003 ; Kwon et al. , 2002 ; Ye and Houle	4165
Dolbeare and Houle , 2003	4165
Dolbeare and Houle	4165
2003	4185
Kwon et al. , 2002	4191
Kwon	4191
et al. , 2002	4196
et al.	4196
2002	4204
Ye and Houle	4210
Ye	4210
Houle	4217
1997 ; Zhou	4224
1997	4224
Zhou	4230
Shine , 2003	4239
Shine	4239
2003	4246
cells	4253
growth factors	4306
Shumsky	4322
et al. , 2003	4330
et al.	4330
2003	4338
treatment with agents that elevate cAMP -LRB- Nikulina et al. , 2004 -RRB-	4345
treatment	4345
agents that elevate cAMP -LRB- Nikulina et al. , 2004 -RRB-	4360
agents	4360
cAMP	4380
Nikulina	4386
et al. , 2004	4395
et al.	4395
2004	4403
combinatorial treatments including Schwann cell transplants	4413
combinatorial treatments	4413
Schwann cell transplants	4448
cAMP or treatment	4487
chondroitinase -LRB- Fouad et al. , 2005 ; Pearse et al. , 2004 -RRB-	4510
chondroitinase	4510
Fouad	4526
et al. , 2005 ; Pearse et al. , 2004	4532
et al.	4532
2005 ; Pearse et al.	4540
2005	4540
Pearse et al.	4546
Pearse	4546
et al.	4553
2004	4561
transfection with constructs	4572
transfection	4572
constructs	4590
growth factors	4610
combination with cAMP -LRB- Lu et al. , 2004 -RRB-	4628
combination	4628
cAMP -LRB- Lu et al. , 2004 -RRB-	4645
cAMP	4645
Lu	4651
et al. , 2004	4654
et al.	4654
2004	4662
Other strategies	4669
molecules	4734
axon regeneration	4768
Nogo and its partners	4791
Nogo	4791
its partners	4800
Lee	4814
et al. , 2003 ; Xu et al. , 2004	4818
et al.	4818
2003 ; Xu et al.	4826
2003	4826
Xu et al.	4832
Xu	4832
et al.	4835
2004	4843
the inhibitors	4850
glial scars -LRB- Chau et al. , 2004 -RRB-	4885
glial scars	4885
Chau	4898
et al. , 2004	4903
et al.	4903
2004	4911
target cell adhesion molecules -LRB- Roonprapunt et al. , 2003 -RRB-	4925
target cell adhesion molecules	4925
Roonprapunt	4957
et al. , 2003	4969
et al.	4969
2003	4977
Demjen	5007
et al. , 2004	5014
et al.	5014
2004	5022
other molecules -LRB- Tanaka et al. , 2004 -RRB-	5032
other molecules	5032
Tanaka	5049
et al. , 2004	5056
et al.	5056
2004	5064
a number of strategies	5080
a number	5080
strategies	5092
promise	5108
repair	5130
regeneration , a barrier	5144
regeneration	5144
a barrier	5158
translation	5171
promising findings	5191
independent replications	5237
this need	5271
the NINDS	5282
`` Facilities of Research-Spinal Cord Injury '' -LRB- FOR-SCI -RRB-	5305
`` Facilities of Research-Spinal Cord Injury ''	5305
Facilities	5306
Research-Spinal Cord Injury	5320
FOR-SCI	5350
promising published studies	5389
we	5453
the results	5463
a replication	5478
an experiment	5495
transplantation	5524
olfactory lamina propria -LRB- OLP -RRB-	5543
olfactory lamina propria	5543
OLP	5569
olfactory ensheathing cells -LRB- OECs -RRB- 1 month	5585
olfactory ensheathing cells -LRB- OECs -RRB-	5585
olfactory ensheathing cells	5585
OECs	5614
1 month	5620
a complete transection of the spinal cord	5634
a complete transection	5634
the spinal cord	5660
recovery of locomotor function	5688
recovery	5688
locomotor function	5700
axon regeneration	5732
rats -LRB- Lu et al. , 2002 -RRB-	5753
rats	5753
Lu	5759
et al. , 2002	5762
et al.	5762
2002	5770
OECs , which are present in the OLP and olfactory bulb ,	5777
OECs	5777
the OLP and olfactory bulb	5804
the OLP	5804
olfactory bulb	5816
a key role	5845
a tissue environment	5868
the growth of axons from the olfactory epithelium	5912
the growth	5912
axons from the olfactory epithelium	5926
axons	5926
the olfactory epithelium	5937
the olfactory bulb	5967
Adult olfactory receptor neurons	5987
continuous turnover	6028
life	6059
the axons of newly formed receptor neurons	6074
the axons	6074
newly formed receptor neurons	6087
a PNS	6133
CNS boundary	6139
their targets	6161
the olfactory bulb -LRB- Ramer et al. , 2004 ; Schwob , 2002 -RRB-	6178
the olfactory bulb	6178
Ramer et al. , 2004 ; Schwob , 2002	6198
Ramer	6198
et al. , 2004 ; Schwob , 2002	6204
et al. , 2004	6204
et al.	6204
2004	6212
Schwob , 2002	6218
Schwob	6218
2002	6226
OECs	6233
antigenic and morphologic characteristics	6246
astrocytes , Schwann cells , and oligodendrocytes	6291
astrocytes	6291
Schwann cells	6303
oligodendrocytes	6322
an array	6351
trophic factors , transcription factors , and extracellular matrix molecules	6363
trophic factors	6363
transcription factors	6380
extracellular matrix molecules	6407
embryonic glia -LRB- Au and Roskams , 2003 ; Newman et al. , 2000 -RRB-	6454
embryonic glia	6454
Au and Roskams , 2003 ; Newman et al. , 2000	6470
Au and Roskams	6470
2003 ; Newman et al.	6486
2003	6486
Newman et al.	6492
Newman	6492
et al.	6499
2000	6507
a number of recent reports	6530
a number	6530
recent reports	6542
OECs	6571
the capability of stimulating axon regeneration	6581
the capability	6581
axon regeneration	6611
the injured CNS	6652
Cao	6669
et al. , 2004	6673
et al.	6673
2004	6681
Chuah et al. , 2004	6687
Chuah	6687
et al. , 2004	6693
et al.	6693
2004	6701
Kato et al. , 2000	6707
Kato	6707
et al. , 2000	6712
et al.	6712
2000	6720
Li et al. , 1997 , 1998	6726
Li	6726
et al. , 1997 , 1998	6729
et al.	6729
1997	6737
1998	6743
Lu et al. , 2001	6749
Lu	6749
et al. , 2001	6752
et al.	6752
2001	6760
Ramer et al. , 2004	6766
Ramer	6766
et al. , 2004	6772
et al.	6772
2004	6780
Ramon-Cueto et al. , 2000	6786
Ramon-Cueto	6786
et al. , 2000	6798
et al.	6798
2000	6806
Transplants of olfactory lamina propria OLP	6813
Transplants	6813
olfactory lamina propria OLP	6828
a dual advantage	6862
a reservoir	6888
OECs	6904
a physical bridge between the exposed stumps of the spinal cord	6930
a physical bridge	6930
the exposed stumps of the spinal cord	6956
the exposed stumps	6956
the spinal cord	6978
One recent report	6995
particular note	7019
substantial recovery of hindlimb motor function	7043
substantial recovery	7043
hindlimb motor function	7067
transplants of OLP	7106
transplants	7106
OLP	7121
the lesion site	7130
1 month	7146
a complete transection of the spinal cord at T10 -LRB- Lu et al. , 2002 -RRB-	7164
a complete transection	7164
the spinal cord at T10 -LRB- Lu et al. , 2002 -RRB-	7190
the spinal cord	7190
T10 -LRB- Lu et al. , 2002 -RRB-	7209
T10	7209
Lu	7214
et al. , 2002	7217
et al.	7217
2002	7225
The recovery	7232
it	7279
a slow regeneration of axons	7322
a slow regeneration	7322
axons	7345
axon regeneration	7361
a manipulation 1 month	7382
a manipulation	7382
1 month	7397
a complete spinal cord transection	7411
a remarkable accomplishment	7449
strong motivation	7507
this strategy	7533
pre-clinical experiments and then	7563
pre-clinical experiments	7563
then	7592
clinical trials	7612
the present study	7642
the initial experiment to determine	7689
the robustness and reliability of the results	7725
the robustness and reliability	7725
the results	7759
Materials and methods Two separate experiments	7773
Materials	7773
methods Two separate experiments	7787
methods	7787
Two separate experiments	7795
Experiment 1 and Experiment 2	7852
Experiment 1	7852
Experiment 2	7869
All experimental protocols and procedures	7884
All experimental protocols	7884
procedures	7915
the Institutional Animal Care and Use Committee	7943
the University of California , Irvine	7994
the University	7994
California , Irvine	8012
All experimental procedures	8032
Lu	8081
et al. , 2002 ,	8084
et al.	8084
2002	8092
minor modifications made to the surgical and postoperative care in Experiment 2	8103
minor modifications	8103
the surgical and postoperative care in Experiment 2	8131
the surgical and postoperative care	8131
Experiment 2	8170
some cases	8187
the original authors	8199
clarification of procedural details	8239
clarification	8239
procedural details	8256
Experimental animals	8276
female Sprague	8302
Dawley rats -LRB- obtained from Harlan Labs -RRB- weighing approximately 250 g	8317
Dawley rats -LRB- obtained from Harlan Labs -RRB-	8317
Dawley rats	8317
Harlan Labs	8344
approximately 250 g	8366
It	8387
the animals used by Lu et al.	8411
the animals	8411
Lu	8431
et al.	8434
a local breeding colony	8451
The original study by Lu et al.	8476
The original study	8476
Lu et al.	8498
Lu	8498
et al.	8501
age	8524
Experiment 1	8540
we	8554
rats that were approximately 5 months old	8562
rats	8562
approximately 5 months	8577
Experiment 2	8609
animals	8623
approximately 4 months	8636
the time of the initial surgery	8666
the time	8666
the initial surgery	8678
Rats	8699
4 -- 5 per cage	8716
4 -- 5	8716
cage	8724
free access	8734
food and water	8749
both experiments	8769
the goal	8787
the spinal cord	8823
T10 in the initial surgery	8842
T10	8842
the initial surgery	8849
Locomotor function	8870
the BBB scale	8906
4 weeks following injury and an additional 10 weeks following transplantation	8924
4 weeks	8924
injury and an additional 10 weeks following transplantation	8942
injury	8942
an additional 10 weeks following transplantation	8953
an additional 10 weeks	8953
transplantation	8986
Animals that exhibited BBB scores greater than 2 prior to transplantation	9003
Animals	9003
BBB scores	9026
greater than 2	9037
transplantation	9061
the study based on the assumption that the lesions were not complete	9098
the study	9098
the assumption	9117
the lesions	9137
Four weeks post-injury , OLP or RLP tissue	9168
Four weeks	9168
post-injury , OLP or RLP tissue	9179
the injury site	9232
We	9268
a lesion	9287
group	9301
this	9315
the original study	9336
Surgical methods Animals	9356
ketamine/xylazine mixture	9404
intraperitoneal 90:10 mg/kg	9431
intraperitoneal	9431
90:10 mg/kg	9447
Body temperature	9461
a heating pad	9498
37 ± 0.5 °C	9515
37 ±	9515
0.5 °C	9520
Experiment 1	9530
transections of the spinal cord	9544
transections	9544
the spinal cord	9560
the T10 level	9589
Lu	9619
et al. -LRB- 2001 -RRB-	9622
et al.	9622
2001	9630
The skin	9637
Betadyne solution	9675
a 1.5 cm incision	9694
the lower thoracic area	9726
muscle and connective tissue	9755
muscle	9755
connective tissue	9766
the T9 -- T11 vertebrae	9817
the T9	9817
T11 vertebrae	9824
A T10 laminectomy	9839
a microsurgery bone rongeur	9877
care	9913
the spinal cord	9932
The spinal cord	9949
a microscalpel	9991
Ophthalmic scalpel NO.	10007
715 , 15 ° ,	10030
715	10030
15 °	10035
Feather	10056
EM Sciences	10083
every effort	10106
the cord	10151
practice	10164
there	10174
considerable displacement	10184
the knife	10213
the spinal cord	10240
Lu	10257
et al. -LRB- 2001 -RRB-	10260
et al.	10260
2001	10268
complete transection	10293
the two stumps of the spinal cord	10315
the two stumps	10315
the spinal cord	10333
a gap of 1	10368
a gap	10368
1	10377
2 mm	10379
2	10379
mm	10381
Experiment 1	10388
this withdrawal	10411
only some animals	10444
other animals	10466
the spinal cord tissue	10481
the gap	10539
the transection site	10550
several animals in Experiment 1	10594
several animals	10594
Experiment 1	10613
incomplete injuries	10630
the analysis	10680
Experiment 2	10697
the surgical procedure	10711
the likelihood that transections were complete	10759
the likelihood	10759
transections	10779
Animals	10807
surgery	10833
laminectomies	10846
A curved suture needle	10895
the spinal cord	10937
the dura mater	10962
the cord	10982
the vertebral column	11019
the cord	11051
1 mm -LRB- Fig. 1 -RRB-	11069
1 mm	11069
Fig. 1	11075
The spinal cord	11084
the ophthalmic scalpel	11126
the suture needle	11158
the transection site	11184
a complete transection	11215
Experiment 2	11242
the two ends of the cord	11256
the two ends	11256
the cord	11272
a gap of 2 -- 3 mm in all animals -LRB- Fig. 1 -RRB-	11305
a gap of 2	11305
a gap	11305
2	11314
3 mm in all animals -LRB- Fig. 1 -RRB-	11316
3 mm	11316
all animals -LRB- Fig. 1 -RRB-	11324
all animals	11324
Fig. 1	11337
completion of the transection injuries	11352
completion	11352
the transection injuries	11366
the connective tissue and muscle	11392
the connective tissue	11392
muscle	11418
5-0 chromic gut	11442
the skin	11463
staples	11489
Bupivacaine -LRB- 0.5 % -RRB-	11498
Bupivacaine	11498
0.5 %	11511
the incision	11537
the surgery	11557
Carprofen -LRB- 5 mg / kg -RRB- was given subcutaneously post-operatively	11574
Carprofen -LRB- 5 mg / kg -RRB-	11574
Carprofen	11574
5 mg	11585
kg	11591
Post-operative care Following the surgery , rats	11638
Post-operative care	11638
the surgery , rats	11668
the surgery	11668
rats	11681
a cage with Alpha - Dri ® and regular bedding	11699
a cage with Alpha	11699
a cage	11699
Alpha	11711
Dri ® and regular bedding	11718
Dri ®	11718
regular bedding	11727
The cage	11744
a heating pad	11767
animals	11786
they	11815
anesthesia	11835
standard tub-style cages	11872
Animals in Experiment 1	11898
Animals	11898
Experiment 1	11909
lactate ringers -LRB- 5 mg/100 g , subcutaneously -RRB-	11931
lactate ringers	11931
5 mg/100 g , subcutaneously	11948
5 mg/100 g	11948
7 days and the analgesic Buprenorphine	11980
7 days	11980
the analgesic Buprenorphine	11991
0.01 -- 0.05 mg/kg	12020
0.01	12020
0.05 mg/kg	12025
14 days	12041
All animals	12063
Baytril -LRB- Enrofloxacin 2.5 mg/kg , subcutaneously -RRB-	12110
Baytril	12110
Enrofloxacin 2.5 mg/kg , subcutaneously	12119
Enrofloxacin 2.5 mg/kg	12119
urinary tract infections -LRB- UTI -RRB- for 14 days	12163
urinary tract infections -LRB- UTI -RRB-	12163
urinary tract infections	12163
UTI	12189
14 days	12198
This protocol	12207
Experiment 2	12237
the animals	12260
triple the lactate ringers -LRB- 15 mg/100 g , subcutaneously -RRB-	12281
triple the lactate ringers	12281
15 mg/100 g , subcutaneously	12309
15 mg/100 g	12309
All other post-operative procedures	12339
Experiments 1 and 2	12394
Rats	12415
twice a day	12435
the post-injury survival period for general health	12458
the post-injury survival period	12458
general health	12494
coat quality -LRB- indicative of grooming activity -RRB-	12510
coat quality	12510
indicative of grooming activity	12524
indicative	12524
grooming activity	12538
mobility within the cage	12562
mobility	12562
the cage	12578
rats	12596
these activities	12618
the day following the injury	12635
the day	12635
the injury	12653
Bladders	12665
the bladder	12716
the animal	12782
an automatic bladder voidance reflex -LRB- range 6 -- 22 days -RRB-	12807
an automatic bladder voidance reflex	12807
range 6 -- 22 days	12845
range 6	12845
22 days	12854
Animals	12864
urinary tract infections -LRB- UTI -RRB- for the entire period of the experiment	12891
urinary tract infections -LRB- UTI -RRB-	12891
urinary tract infections	12891
UTI	12917
the entire period of the experiment	12926
the entire period	12926
the experiment	12947
an animal	12966
general debilitation , vaginal inflammation , or discharge indicative of a UTI	12986
general debilitation	12986
vaginal inflammation	13008
discharge indicative of a UTI	13033
discharge indicative	13033
a UTI	13057
they	13064
the antibiotic Baytril	13087
Only one animal , in Experiment 2 ,	13111
Only one animal	13111
Experiment 2	13131
signs of a UTI	13155
signs	13155
a UTI	13164
14 days	13176
this animal	13197
a single dose of Baytril	13218
a single dose	13218
Baytril	13235
Animals	13257
any sign of skin lesions or autophagia	13289
any sign	13289
skin lesions or autophagia	13301
skin lesions	13301
autophagia	13317
animals	13334
exhibit autophagia	13346
the affected limbs	13366
1 % silver sulfadiazine cream	13403
1 %	13403
silver sulfadiazine cream	13406
Dissection and preparation	13433
Dawley	13531
250 g	13544
sodium pentobarbital -LRB- 100 mg/kg -RRB-	13581
sodium pentobarbital	13581
100 mg/kg	13603
decapitation	13628
Olfactory lamina propria -LRB- OLP -RRB-	13642
Olfactory lamina propria	13642
OLP	13668
respiratory lamina propria -LRB- RLP -RRB-	13677
respiratory lamina propria	13677
RLP	13705
the protocol	13735
Dr. Jane Roskam 's , University	13761
Dr. Jane Roskam 's	13761
University	13780
British Columbia , Canada , as follows	13794
British Columbia	13794
Canada	13812
The skull	13832
a mid-sagittal incision	13857
The head	13882
the midline	13913
a single-edge razor -LRB- solid line in Fig. 2A -RRB-	13931
a single-edge razor	13931
solid line in Fig. 2A	13952
solid line	13952
Fig. 2A	13966
the nasal septum	13994
the	14016
OE	14051
RE	14080
the olfactory bulb -LRB- Fig. 2B -RRB-	14089
the olfactory bulb	14089
Fig. 2B	14109
Turbinates present over the septum	14119
Turbinates	14119
the septum	14143
forceps	14173
The nasal septum	14182
a scalpel -LRB- red line -RRB-	14213
a scalpel	14213
red line	14224
care	14242
the cribriform plate and skull	14256
the cribriform plate	14256
skull	14281
the septum to be separated from the overlying tissue and away	14297
the overlying tissue and away	14329
the rest of the head -LRB- Fig. 2C -RRB-	14364
the rest	14364
the head -LRB- Fig. 2C -RRB-	14376
the head	14376
Fig. 2C	14386
Olfactory mucosa	14396
the most caudal end of the nasal septum , all of which is olfactory	14428
the most caudal end	14428
the nasal septum , all of which is olfactory	14451
the nasal septum	14451
Respiratory mucosa	14496
the dorsal -- anterior region of the septum	14532
the dorsal	14532
anterior region of the septum	14543
anterior region	14543
the septum	14562
The red lines in Fig. 2	14574
The red lines	14574
Fig. 2	14591
the cuts made to isolate OLP and RLP respectively	14607
the cuts	14607
OLP and RLP	14632
The RLP	14658
the OLP	14682
olfactory ensheathing cells	14704
The vomeronasal nerve courses	14733
the RLP	14776
the respiratory tissue -LRB- Fig. 2D -RRB-	14803
the respiratory tissue	14803
Fig. 2D	14827
The nasal septum containing the OLP and RLP	14837
The nasal septum	14837
the OLP and RLP	14865
a petri dish	14895
DMEM/F12 tissue culture media	14919
Dulbecco 's Modified Eagle Medium with serum , Gibco , USA	14950
Dulbecco	14950
's	14958
Eagle Medium	14970
serum , Gibco , USA	14988
serum	14988
Gibco , USA	14995
a scalpel blade	15014
the olfactory mucosa	15031
the sides	15059
the posterior part of the septum	15072
the posterior part	15072
the septum	15094
two	15109
pieces of the respiratory mucosa lining the anterior part of the septum	15129
pieces	15129
the respiratory mucosa lining the anterior part of the septum	15139
the respiratory mucosa	15139
the anterior part of the septum	15169
the anterior part	15169
the septum	15190
Fig. 3A	15228
ice-cold DMEM/F12	15262
The olfactory mucosa	15281
the rat	15326
its posterior position on the nasal septum	15337
its posterior position	15337
the nasal septum	15363
the yellowish appearance of the epithelial surface	15387
the yellowish appearance	15387
the epithelial surface	15415
Care	15439
the anterior edge	15463
the olfactory mucosa , which could be contaminated with respiratory epithelium	15484
the olfactory mucosa	15484
respiratory epithelium	15539
Respiratory epithelium	15563
the dorsal	15603
anterior region of the septum along the lines	15614
anterior region	15614
the septum along the lines	15633
the septum	15633
the lines	15650
Fig. 3B	15673
The distinctly different cellular composition	15682
the tissue resulting from these dissections	15731
the tissue	15731
these dissections	15757
Fig. 4	15793
The dissected OE -LRB- Figs. 4A -- C -RRB-	15801
The dissected OE	15801
Figs. 4A -- C	15819
Figs. 4A	15819
C	15828
its tightly packed cell layers	15839
only trace basal lamina laminin staining -LRB- Fig. 4A , green -RRB-	15880
only trace basal lamina laminin staining	15880
only trace	15880
basal lamina laminin staining	15891
Fig. 4A	15922
green	15931
the basal surface	15941
multiple layers	15973
NCAM -LRB- Fig. 4B , green -RRB- - and OMP -LRB- Fig. 4C , green -RRB-	15992
NCAM -LRB- Fig. 4B , green -RRB-	15992
NCAM	15992
Fig. 4B	15998
green	16007
OMP -LRB- Fig. 4C , green -RRB-	16019
OMP	16019
Fig. 4C	16024
green	16033
neuronal cell bodies	16051
The dissected LP -LRB- D -- F -RRB-	16073
The dissected LP	16073
D -- F	16091
D	16091
F	16093
S100-β	16105
ensheathing cells -LRB- Fig. 4D , red -RRB- and NST -LRB- Fig. 4E , red -RRB-	16124
ensheathing cells -LRB- Fig. 4D , red -RRB-	16124
ensheathing cells	16124
Fig. 4D	16143
red	16152
NST -LRB- Fig. 4E , red -RRB-	16161
NST	16161
Fig. 4E	16166
red	16175
OMP	16184
Fig. 4F	16189
red	16198
axon bundles ensheathed in laminin -LRB- green -RRB-	16203
axon bundles	16203
laminin	16230
OECs	16254
no neuronal cell	16269
The respiratory and the olfactory tissues	16294
The respiratory	16294
the olfactory tissues	16314
separate wells of a 24-well tissue culture plate	16356
separate wells	16356
a 24-well tissue culture plate	16374
2.4 units/ml	16422
dispase II solution -LRB- Boehringer , company -RRB- at 37 °C	16435
dispase II solution -LRB- Boehringer , company -RRB-	16435
dispase II solution	16435
Boehringer	16456
company	16468
37 °C	16480
Olfactory tissue	16486
90 min	16521
respiratory tissue	16533
60 min	16570
37 °C	16580
shorter incubation times	16586
RLP	16625
the tissue fragmented after enzymatic treatment for longer periods	16637
the tissue	16637
enzymatic treatment for longer periods	16665
enzymatic treatment	16665
longer periods	16689
enzymatic digestion	16712
the tissue	16733
DMEM/F12 medium	16760
a 35 mm dish	16790
fresh DMEM/F12	16814
both cases	16833
LP	16845
the epithelium under the dissection microscope	16877
the epithelium	16877
the dissection microscope	16898
micro-forceps	16930
This method	16945
the olfactory epithelium from the OLP	16967
the olfactory epithelium	16967
the OLP	16997
contamination of one with the other -LRB- Figs. 3C -- E -RRB-	17013
contamination	17013
one with the other -LRB- Figs. 3C -- E -RRB-	17030
one	17030
the other -LRB- Figs. 3C -- E -RRB-	17039
the other	17039
Figs. 3C -- E	17050
Figs. 3C	17050
E	17059
Approximately 6 -- 8 mm2 of OLP and RLP tissue	17063
Approximately 6 -- 8 mm2 of OLP	17063
Approximately 6	17063
8 mm2 of OLP	17079
8 mm2	17079
OLP	17088
RLP tissue	17096
each side of the nasal septum	17125
each side	17125
the nasal septum	17138
These	17156
pieces that were approximately 1 mm2 for grafting	17181
pieces	17181
approximately 1 mm2 for grafting	17198
approximately 1 mm2	17198
grafting	17222
The tissue	17232
ice	17255
transplantation	17265
the host -LRB- approximately 1 -- 2 h -RRB-	17286
the host	17286
approximately 1 -- 2 h	17296
approximately 1	17296
2 h	17312
Experiment 1	17321
OLP and RLP tissue for transplantation	17335
OLP and RLP tissue	17335
transplantation	17358
nine donor rats	17392
Experiment 2	17412
OLP and RLP tissue	17426
10 donor rats	17463
Experiment 1	17481
the OLP and RLP tissue	17495
10 % nuclear fluorochrome bisbenzimide -LRB- Sigma -RRB-	17535
10 % nuclear fluorochrome bisbenzimide	17535
10 % nuclear fluorochrome	17535
Sigma	17574
37 °C for 2 h	17584
37 °C	17584
2 h	17593
Lu	17613
et al. -LRB- 2002 -RRB-	17616
et al.	17616
2002	17624
3 times	17650
DMEM without serum	17663
DMEM	17663
serum	17676
This step	17683
Experiment 2 due to concerns about tissue viability	17708
Experiment 2	17708
concerns about tissue viability	17728
concerns	17728
tissue viability	17743
the labeling period	17767
findings from Experiment 1	17799
findings	17799
Experiment 1	17813
bisbenzimide	17841
tissue	17873
fixation	17891
the label	17909
a valid marker for transplanted tissue	17930
a valid marker	17930
transplanted tissue	17949
Transplantation	17970
lamina propria Four weeks following the transection injuries , rats	17989
lamina propria	17989
Four weeks	18004
the transection injuries , rats	18025
the transection injuries	18025
rats	18051
intraperitoneal ketamine/xylazine : 90:10 mg / kg	18078
intraperitoneal ketamine/xylazine	18078
90:10 mg / kg	18113
90:10 mg	18113
kg	18123
the original incision	18132
the dorsal laminectomy	18172
the T9 -- T11 level cutting about halfway through the T9 and T11 vertebrae	18211
the T9	18211
T11 level cutting about halfway through the T9 and T11 vertebrae	18218
T11 level	18218
the T9 and T11 vertebrae	18258
a surgical microscope	18290
scar tissue from the previous transection site	18313
scar tissue	18313
the previous transection site	18330
normal-appearing spinal cord tissue	18378
Fig. 5A	18435
removal of the scar tissue	18451
removal	18451
the scar tissue	18462
the gap between the caudal and the rostral stumps	18479
the gap	18479
the caudal and the rostral stumps	18495
the caudal	18495
the rostral stumps	18510
approximately 3 mm in longitudinal extent	18533
approximately 3 mm	18533
longitudinal extent	18555
The lesion site	18576
0.9 % saline	18611
Gelfoam	18628
the lesion cavity	18650
hemostasis	18679
homeostasis	18697
the Gelfoam	18728
7 -- 8 pieces of OLP or RLP	18757
7	18757
8 pieces of OLP or RLP	18759
8 pieces	18759
OLP or RLP	18771
the gap	18802
Gelfoam -LRB- Fig. 5B -RRB-	18832
Gelfoam	18832
Fig. 5B	18841
The wound	18851
the muscle and skin layers	18889
Post-operative care	18926
Bladder assessment Following surgery , rat 's bladders	18979
Bladder assessment	18979
surgery , rat 's bladders	19008
surgery	19008
rat 's bladders	19017
rat 's	19017
Experiment 1	19063
the urine	19077
three times each week -LRB- Monday , Wednesday , and Friday -RRB-	19113
three times each week	19113
three times	19113
each week	19125
Monday , Wednesday , and Friday	19136
Monday	19136
Wednesday	19144
Friday	19159
order	19170
a measure of urine retention , and thus bladder dysfunction ,	19187
a measure of urine retention	19187
a measure	19187
urine retention	19200
bladder dysfunction	19226
the entire period of the experiment	19251
the entire period	19251
the experiment	19272
the time of the transection until the animals were euthanized	19293
the time	19293
the transection until the animals were euthanized	19305
the transection	19305
the animals	19327
Urine	19356
a weigh boat	19390
volume	19425
Assessment	19433
hindlimb motor function Following the surgeries , hindlimb motor function	19447
hindlimb motor function	19447
the surgeries , hindlimb motor function	19481
the surgeries	19481
hindlimb motor function	19496
the BBB scale	19539
a week	19558
a total	19569
14 weeks	19580
4 weeks following spinal cord transection and 10 weeks following transplantation	19590
4 weeks	19590
spinal cord transection and 10 weeks following transplantation	19608
spinal cord transection	19608
10 weeks following transplantation	19636
10 weeks	19636
transplantation	19655
BBB testing	19687
bladders	19700
animals	19728
at least 15 min	19750
any spastic movements of the hindlimbs related to bladder fullness	19787
any spastic movements	19787
the hindlimbs related to bladder fullness	19812
the hindlimbs	19812
bladder fullness	19837
BBB assessment	19859
rats	19875
an open field -LRB- 150 × 100 cm -RRB-	19895
an open field	19895
150 × 100 cm	19910
150 ×	19910
100 cm	19916
Hindlimb motor function	19925
two observers who were blind to the transplantation status of the animals	19978
two observers	19978
the transplantation status of the animals	20010
the transplantation status	20010
the animals	20040
Raters	20053
the animals ' performance	20070
the animals '	20070
the testing	20102
various manipulations	20128
ambulation , as is the standard for the BBB assessment	20162
ambulation	20162
the standard for the BBB assessment	20180
the standard	20180
the BBB assessment	20197
Retrograde	20217
cells giving rise to descending axons	20239
cells	20239
rise	20252
descending axons	20260
Ten weeks following transplantation	20277
Ten weeks	20277
transplantation	20297
rats	20314
The laminectomy	20357
the T12 vertebra	20397
the spinal cord caudal	20424
the transection	20450
The retrograde tracer	20467
Fluorogold	20490
2 % dextran tetramethylenerhodamine	20502
2 %	20502
dextran tetramethylenerhodamine	20505
10,000 MW ; Flurochrome , LLC	20538
10,000 MW	20538
Flurochrome , LLC	20549
the lumbar spinal cord about 1	20586
the lumbar spinal cord	20586
1	20615
2 mm caudal to the transection site	20617
2 mm caudal	20617
the transection site	20632
0.5 μl syringes	20659
Scientific Glass Engineering , Melbourne , Australia	20689
Scientific Glass Engineering	20689
Melbourne , Australia	20719
Three injections -LRB- 0.05 μl each -RRB-	20741
Three injections	20741
0.05 μl each	20759
0.05 μl	20759
each	20767
the midline	20786
0.5 , 0.8 , and 1.5 mm deep	20802
0.5 , 0.8 , and 1.5	20802
mm	20820
1 mm lateral	20833
0.4 , 0.8 , and 1.2 mm deep	20847
0.4 , 0.8 , and 1.2	20847
mm deep	20865
each side over a period of 3 min	20877
each side	20877
a period of 3 min	20892
a period	20892
3 min	20904
Similar injections	20911
3 noninjured control rats	20945
neurons that normally project to the lumbar enlargement	20983
neurons	20983
project	21005
the lumbar enlargement	21016
Post-operative care	21040
Histological assessment Four days	21084
Histological assessment	21084
Four days	21108
the injections of Fluorogold	21128
the injections	21128
Fluorogold	21146
animals	21158
an anesthetic overdose	21175
4 % paraformaldehyde in 0.1 M phosphate buffer , pH 7.4	21236
4 % paraformaldehyde	21236
0.1 M phosphate buffer , pH 7.4	21259
0.1 M phosphate buffer	21259
pH 7.4	21283
The spinal cord and brain	21291
The spinal cord	21291
brain	21311
the same fixative	21345
30 % sucrose	21385
A 1.6 mm block	21398
the injury/transplant site	21424
8 mm rostral and 8 mm caudal	21465
8 mm rostral	21465
8 mm caudal	21482
the epicenter	21497
OCT	21527
immersion in liquid nitrogen	21545
immersion	21545
liquid nitrogen	21558
The remaining segments of the spinal cord rostral and caudal to the injury	21575
The remaining segments	21575
the spinal cord rostral and caudal to the injury	21601
the spinal cord rostral and caudal	21601
the injury	21639
OCT	21672
immersion in liquid nitrogen	21690
immersion	21690
liquid nitrogen	21703
The block containing the lesion/transplant site	21720
The block	21720
the lesion/transplant site	21741
the sagittal plane	21785
tissue	21809
the blocks	21863
the rostral and caudal portions of the spinal cord	21885
the rostral	21885
caudal portions of the spinal cord	21901
caudal portions	21901
the spinal cord	21920
the transverse plane	21954
Brains	21976
the coronal plane	22001
25 μm on a cryostat	22022
25 μm	22022
a cryostat	22031
Sections	22043
250 μm	22052
PBS	22091
slides	22111
The distribution of fluorescent retrogradely labeled cells	22119
The distribution	22119
fluorescent retrogradely labeled cells	22139
fluorescent retrogradely	22139
cells	22172
an Olympus IX80 microscope	22197
Digital photomicrographs	22225
the MagnaFIRE ® system	22267
Hoechst labeling	22290
Experiment 1	22326
OLP and RLP tissue	22340
bisbenzimide	22376
transplantation	22398
one section	22428
every three sagittal sections through the lesion/transplant site	22447
every three sagittal sections	22447
the lesion/transplant site	22485
slides	22538
the nuclear	22561
Hoechst in the transplanted spinal cord -LRB- as in Lu et al. -RRB-	22579
Hoechst	22579
the transplanted spinal cord -LRB- as in Lu et al. -RRB-	22590
the transplanted spinal cord	22590
Lu et al.	22626
Lu	22626
et al.	22629
Serotonin histochemistry	22638
serotonin -LRB- 5HT -RRB-	22667
serotonin	22667
5HT	22678
immunostaining	22683
every third section	22699
the series of serial sagittal sections through the lesion/transplant site	22722
the series	22722
serial sagittal sections through the lesion/transplant site	22736
serial sagittal sections	22736
the lesion/transplant site	22769
Bond-Rite ® slides	22813
Transverse sections through the rostral and caudal blocks	22832
Transverse sections	22832
the rostral and caudal blocks	22860
the same way	22906
The sections	22920
phosphate-buffered saline -LRB- PBS -RRB-	22948
phosphate-buffered saline	22948
PBS	22975
5 % normal goat serum	22999
PBS	23023
sections	23028
primary antibody at 4 °C overnight	23055
primary antibody at 4 °C	23055
primary antibody	23055
4 °C	23075
rabbit anti-serotonin , Sigma S-5545	23090
rabbit anti-serotonin	23090
Sigma S-5545	23113
1:5000 in PBS	23127
1:5000	23127
PBS	23137
5 % normal goat serum	23147
The following day	23169
sections	23188
PBS	23212
the fluorescent secondary antibody	23235
goat-anti-rabbit IgG , Alexa	23271
goat-anti-rabbit IgG	23271
Alexa	23293
Fluor 488 , 1:250 in PBS	23300
Fluor 488 , 1:250	23300
PBS	23320
5 % normal goat serum	23330
0.5 % Triton X-100 for 1 h	23355
0.5 % Triton X-100	23355
1 h	23377
room temperature	23384
The sections	23402
three times	23432
PBS	23447
Kaiser 's glycerol jelly	23473
Kaiser 's	23473
Results	23499
1	23512
spinal cord transection procedure used in Experiment 2	23524
spinal cord transection procedure	23524
Experiment 2	23566
A curved suture needle	23580
the spinal cord	23622
the cord	23653
the vertebral column -LRB- A -RRB-	23672
the vertebral column	23672
A	23694
The spinal cord	23698
a micro-scalpel -LRB- B -RRB-	23740
a micro-scalpel	23740
B	23757
transection	23767
the ends of the spinal cord	23780
the ends	23780
the spinal cord	23792
a 2 -- 3 mm gap -LRB- C -RRB-	23829
a 2	23829
3 mm gap -LRB- C -RRB-	23833
3 mm gap	23833
C	23843
Fig. 2 .	23848
Fig.	23848
2	23853
Diagrammatic illustration	23856
the dissection of the olfactory and respiratory lamina propria	23885
the dissection	23885
the olfactory and respiratory lamina propria	23903
the nasal septum	23953
This method	23971
Dr. Jane Roskam 's laboratory , University of British Columbia , Canada	24000
Dr. Jane Roskam 's laboratory	24000
Dr. Jane Roskam 's	24000
University of British Columbia , Canada	24030
University	24030
British Columbia , Canada	24044
British Columbia	24044
Canada	24062
Materials and methods for details	24074
Materials	24074
methods for details	24088
methods	24088
details	24100
-LRB- A -RRB- Off-center sagittal bisection	24109
-LRB- A -RRB-	24109
Off-center sagittal bisection	24113
-LRB- B -RRB- sagittal view	24144
-LRB- B -RRB-	24144
sagittal view	24148
-LRB- C -RRB- dissection of nasal septum	24163
dissection	24167
nasal septum	24181
-LRB- D -RRB- features of nasal septum	24195
-LRB- D -RRB- features	24195
D	24196
nasal septum	24211
OB , olfactory bulb	24225
OB	24225
olfactory bulb	24229
OE , olfactory epithelium	24245
OE	24245
olfactory epithelium	24249
RE , respiratory epithelium	24271
RE	24271
respiratory epithelium	24275
VNO , vomeronasal nerve	24299
VNO	24299
vomeronasal nerve	24304
Fig. 3 .	24324
Fig.	24324
3	24329
Dissection	24332
olfactory lamina propria	24346
OLP	24372
respiratory lamina propria	24381
RLP	24409
-LRB- A -RRB- Nasal septum in situ in the skull	24415
-LRB- A -RRB- Nasal septum	24415
A	24416
situ in the skull	24435
situ	24435
the skull	24443
-LRB- B -RRB- nasal septum following dissection	24454
-LRB- B -RRB- nasal septum	24454
B	24455
dissection	24481
Red and blue	24493
Red	24493
blue	24501
OLP and RLP	24515
Panels C -- E illustrate the separation of the OLP and RLP .	24542
Panels C	24542
E	24551
the separation of the OLP and RLP	24564
the separation	24564
the OLP and RLP	24582
OE , olfactory epithelium ; LP , lamina propria .	24599
OE , olfactory epithelium	24599
OE	24599
olfactory epithelium	24603
LP , lamina propria	24625
LP	24625
lamina propria	24629
Fig. 4 .	24646
Fig.	24646
4	24651
LP and OE	24654
each other	24694
dissection	24716
the OE -LRB- A -- C -RRB-	24728
the OE	24728
A -- C	24736
A	24736
C	24738
its tightly packed cell layers	24749
only trace basal lamina laminin staining -LRB- A , green -RRB-	24790
only trace basal lamina laminin staining	24790
only trace	24790
basal lamina laminin staining	24801
A , green	24832
A	24832
green	24835
the basal surface -LRB- arrowheads -RRB-	24845
the basal surface	24845
multiple layers of NCAM -LRB- B , green -RRB- - and OMP -LRB- C , green -RRB-	24889
multiple layers	24889
NCAM -LRB- B , green -RRB- - and OMP -LRB- C , green -RRB-	24908
NCAM -LRB- B , green -RRB-	24908
NCAM	24908
B , green	24914
B	24914
green	24917
OMP -LRB- C , green -RRB-	24929
OMP	24929
C , green	24934
C	24934
green	24937
neuronal cell bodies	24955
The LP -LRB- D -- F -RRB-	24977
The LP	24977
D -- F	24985
D	24985
F	24987
S100-β-expressing ensheathing cells -LRB- D , red -RRB-	24999
S100-β-expressing ensheathing cells	24999
D , red	25036
D	25036
red	25039
NST -LRB- E , red -RRB-	25048
NST	25048
E , red	25053
E	25053
red	25056
OMP	25065
F , red	25070
F	25070
red	25073
axon bundles ensheathed in laminin -LRB- green -RRB-	25078
axon bundles	25078
laminin	25105
OECs	25129
no neuronal cell	25144
Fig. 5 .	25170
Fig.	25170
5	25175
Removal	25178
scar tissue	25189
the transection site and transplantation	25204
olfactory lamina propria	25248
OLP	25274
respiratory lamina propria	25282
RLP	25310
-LRB- A -RRB- Illustration of the cavity	25316
-LRB- A -RRB-	25316
the cavity	25336
a result of the removal of the scar tissue	25357
a result	25357
the removal of the scar tissue	25369
the removal	25369
the scar tissue	25384
the second operation 30 days post-transection	25403
the second operation	25403
30 days	25424
-LRB- B -RRB- Appearance of transplanted tissue in the lesion gap .	25450
-LRB- B -RRB-	25450
Appearance	25454
transplanted tissue in the lesion gap	25468
transplanted tissue	25468
the lesion gap	25491
Arrows	25507
the lesion site , which in panel B is filled with transplanted tissue	25523
the lesion site	25523
panel B	25549
transplanted tissue	25572
Fig. 6 .	25594
Fig.	25594
6	25599
BBB scores	25602
transection of the spinal cord	25623
transection	25623
the spinal cord	25638
delayed transplantation of OLP or RLP -LRB- Experiment 1 -RRB-	25658
delayed transplantation	25658
OLP or RLP -LRB- Experiment 1 -RRB-	25685
OLP or RLP	25685
Experiment 1	25697
Vertical arrows	25712
numbers and groups	25750
numbers	25750
groups	25762
the time	25778
animals	25796
the analysis due to death -LRB- # 2 -RRB- or autophagia -LRB- # 12 , 28 -RRB-	25825
the analysis	25825
death -LRB- # 2 -RRB- or autophagia -LRB- # 12 , 28 -RRB-	25845
death	25845
# 2	25852
autophagia	25859
# 12 , 28	25871
# 12	25871
28	25876
Scores for these animals	25881
Scores	25881
these animals	25892
the time of death or onset of autophagia	25915
the time	25915
death or onset of autophagia	25927
death or onset	25927
autophagia	25945
the graph	25972
Fig. 7 .	25984
Fig.	25984
7	25989
Urine volumes	25992
transection of the spinal cord and delayed transplantation of OLP or RLP	26016
transection of the spinal cord	26016
transection	26016
the spinal cord	26031
delayed transplantation of OLP or RLP	26051
delayed transplantation	26051
OLP or RLP	26078
Transected animals	26090
higher than normal urine volumes during the initial 10 days	26118
higher than normal urine volumes	26118
the initial 10 days	26158
urine volumes	26196
control levels	26226
10 days	26247
Animal # 2	26256
Animal	26256
analysis	26295
the vertical arrows	26320
Fig. 8 .	26342
Fig.	26342
8	26347
Morphology of the spinal cords from animals	26350
Morphology	26350
the spinal cords from animals	26364
the spinal cords	26364
animals	26386
Experiment 1	26406
Numbers	26420
animal numbers	26437
the text	26465
animal # 12 and 28 exhibited autophagia at the times	26475
animal	26475
# 12 and 28	26482
# 12	26482
28	26490
autophagia	26503
the times	26517
Fig. 6	26540
Fig. 9 .	26549
Fig.	26549
9	26554
Hoechst-labeled cells in the transplant site .	26557
Hoechst-labeled cells	26557
the transplant site	26582
Panels A and B	26603
Panels	26603
A and B	26610
Hoechst-labeled nuclei in sagittal sections	26629
Hoechst-labeled nuclei	26629
sagittal sections	26655
the lesion epicenter and transplant site	26681
animals that received OLP -LRB- A -RRB- or RLP -LRB- B -RRB- transplants	26725
animals	26725
OLP -LRB- A -RRB- or RLP -LRB- B -RRB- transplants	26747
OLP -LRB- A -RRB-	26747
OLP	26747
A	26752
RLP -LRB- B -RRB-	26758
RLP	26758
B	26763
transplants	26766
Arrows	26779
identifiable structures	26795
the sections	26822
the same sections	26860
H&E	26897
Fig. 10	26902
Fig. 10 .	26913
Fig.	26913
10	26918
sections	26934
cases that received OLP and RLP transplants	26948
cases	26948
OLP and RLP transplants	26968
Panels A and B	26993
Panels	26993
A and B	27000
the appearance of the transplants in sagittal sections	27019
the appearance	27019
the transplants in sagittal sections	27037
the transplants	27037
sagittal sections	27056
the lesion epicenter and transplant site	27082
animals that received OLP -LRB- A -RRB- or RLP -LRB- B -RRB- transplants	27126
animals	27126
OLP -LRB- A -RRB- or RLP -LRB- B -RRB- transplants	27148
OLP -LRB- A -RRB-	27148
OLP	27148
A	27153
RLP -LRB- B -RRB-	27159
RLP	27159
B	27164
transplants	27167
These	27180
the same	27190
Fig. 9	27214
Arrows	27222
identifiable structures	27238
the sections that can also be seen in the images in Fig. 9	27265
the sections	27265
the images in Fig. 9	27303
the images	27303
Fig. 9	27317
Fig. 11 .	27326
Fig.	27326
11	27331
BBB scores for animals	27335
BBB scores	27335
animals	27350
Experiment 2	27370
Vertical arrow	27384
the time at which one animal -LRB- # 6 -RRB- died	27409
the time	27409
one animal -LRB- # 6 -RRB-	27427
one animal	27427
# 6	27439
Scores for this animal prior to the time of death	27449
Scores	27449
this animal prior to the time of death	27460
this animal	27460
the time of death	27481
the time	27481
death	27493
the analysis	27515
Fig. 12 .	27530
Fig.	27530
12	27535
Morphology of the spinal cords for the animals	27539
Morphology	27539
the spinal cords for the animals	27553
the spinal cords	27553
the animals	27574
Experiment 2	27598
Numbers	27612
animal numbers	27629
Care	27645
the transplanted tissue	27674
the lesion site	27701
appurtenant scar tissue	27725
Fig. 13 .	27767
Fig.	27767
13	27772
Histology of the spinal cord for animals	27776
Histology	27776
the spinal cord for animals	27789
the spinal cord	27789
animals	27809
Experiment 2	27829
The figures illustrate representative	27843
The figures	27843
sections	27893
-LRB- A -RRB- Section from an animal that received an OLP transplant .	27903
-LRB- A -RRB-	27903
Section	27907
an animal that received an OLP transplant	27920
an animal	27920
an OLP transplant	27944
-LRB- B -RRB- Section from an animal that received an RLP transplant .	27963
-LRB- B -RRB-	27963
Section	27967
an animal that received an RLP transplant	27980
an animal	27980
an RLP transplant	28004
the transection site	28033
transplanted tissue	28069
these transplants	28098
the gap between rostral and caudal segments	28123
the gap	28123
rostral and caudal segments	28139
Bridging	28168
other animals	28198
some animals	28217
large cavities and much thinner tissue bridges	28240
seen in these `` best case '' examples	28292
these `` best case ''	28300
these	28300
best case	28307
-LRB- C -RRB- Higher power view of the section	28328
-LRB- C -RRB- Higher power view	28328
-LRB- C -RRB-	28328
Higher power view	28332
the section	28353
panel A	28380
This section	28389
approximately 75 μm	28405
the section illustrated in Fig. 16G	28435
the section	28435
Fig. 16G	28462
The football-shaped cavity	28472
Fig. 16G	28514
Fig. 14 .	28525
Fig.	28525
14	28530
BBB scores	28543
animals	28558
Experiments 1 and 2	28569
Arrows	28590
the days	28606
animals	28624
analysis	28650
death or severe autophagia	28666
death	28666
severe autophagia	28675
Fig. 15 .	28695
Fig.	28695
15	28700
Retrograde labeling	28704
neurons	28727
the brainstem that give rise to projections to lumbar segments in normal animals	28738
the brainstem	28738
rise	28762
projections to lumbar segments in normal animals	28770
projections	28770
lumbar segments in normal animals	28785
lumbar segments	28785
normal animals	28804
-LRB- A -RRB- The photomicrograph	28820
-LRB- A -RRB-	28820
The photomicrograph	28824
the pattern of labeling in un-injured control rats 2 days	28856
the pattern	28856
labeling in un-injured control rats 2 days	28871
labeling	28871
un-injured control rats	28883
2 days	28907
Fluorogold	28933
the lumbar enlargement	28949
Arrows	28973
neurons in several brainstem nuclei	28997
neurons	28997
several brainstem nuclei	29008
-LRB- B -RRB- The photomicrograph	29034
-LRB- B -RRB-	29034
The photomicrograph	29038
a similar section	29070
an animal	29093
a transplant	29108
an injection of Fluorogold	29139
an injection	29139
Fluorogold	29155
the lumbar enlargement	29171
2 days	29194
death	29210
Note absence of retrogradely	29217
Note absence	29217
retrogradely	29233
neurons	29254
No retrogradely labeled neurons	29263
No retrogradely	29263
neurons	29287
any animals with spinal cord transections and either OLP or RLP transplants	29312
any animals with spinal cord transections	29312
any animals	29312
spinal cord transections	29329
either OLP or RLP transplants	29358
OLP	29365
RLP transplants	29372
Fig. 16 .	29390
Fig.	29390
16	29395
Pattern	29399
labeling	29410
5HT rostral and caudal	29423
the transection	29449
animals that received OLP or RLP transplants	29468
animals	29468
OLP or RLP transplants	29490
Panels A and B	29514
Panels	29514
A and B	29521
the pattern of labeling for 5HT	29540
the pattern	29540
labeling for 5HT	29555
labeling	29555
5HT	29568
rostral and caudal segments	29575
an animal that received an RLP transplant -LRB- animal # 35 -RRB-	29606
an animal	29606
an RLP transplant	29630
animal # 35	29649
animal	29649
# 35	29656
Panel C	29662
5HT axons	29682
the caudal segment at higher magnification	29695
the caudal segment	29695
higher magnification	29717
Panels D and H	29739
Panels	29739
examples	29765
the small numbers	29777
labeled axons	29798
caudal segments	29820
the OLP recipient rat	29839
# 10	29862
the largest number of 5HT axons	29882
the largest number	29882
5HT axons	29904
caudal segments	29917
These sections	29934
nearby one	29953
another	29964
The section in panel H	29973
The section	29973
panel H	29988
one example of a small axon arbor generated by a 5HT axon	30008
one example	30008
a small axon arbor generated by a 5HT axon	30023
a small axon arbor	30023
a 5HT axon	30055
Panels E and F	30067
Panels E	30067
F	30080
5HT axons rostral	30093
the lesion/transplant site	30121
the animal	30151
the largest number of 5HT axons	30177
the largest number	30177
5HT axons	30199
caudal segments that had received an RLP transplant -LRB- animal # 35 -RRB-	30212
caudal segments	30212
an RLP transplant -LRB- animal # 35 -RRB-	30246
an RLP transplant	30246
animal # 35	30265
animal	30265
# 35	30272
Panel G	30278
5HT axons rostral	30298
the lesion/transplant site	30326
the animal	30356
the largest number of 5HT axons	30382
the largest number	30382
5HT axons	30404
caudal segments that had received an OLP transplant -LRB- animal # 10 -RRB-	30417
caudal segments	30417
an OLP transplant -LRB- animal # 10 -RRB-	30451
an OLP transplant	30451
animal # 10	30470
animal	30470
# 10	30477
we	30501
the results for Experiments 1 and 2 separately	30512
the results	30512
Experiments 1 and 2	30528
the combined results from the two experiments	30568
the combined results	30568
the two experiments	30594
Experiment 1 Attrition following transection surgery Our goal	30615
Experiment 1 Attrition	30615
transection surgery Our goal	30648
transection surgery	30648
Our goal	30668
group sizes	30691
the OLP and RLP groups	30707
the group sizes of the Lu et al. study -LRB- n = 6 for OLP ; n = 7 for RLP -RRB-	30761
the group sizes	30761
the Lu et al. study -LRB- n = 6 for OLP ; n = 7 for RLP -RRB-	30780
the Lu et al. study	30780
the Lu	30780
et al. study	30787
n = 6 for OLP ; n = 7 for RLP	30801
n	30801
= 6 for OLP ; n = 7 for RLP	30803
= 6 for OLP	30803
= 6	30803
OLP	30811
n = 7 for RLP	30816
n = 7	30816
n	30816
7	30820
RLP	30826
We	30832
there	30848
some incomplete lesions and attrition	30863
various reasons	30905
more animals than would be needed	30942
more animals	30942
5 rats	30985
the 4 weeks following transections and prior to transplantation	31004
the 4 weeks	31004
transections and prior to transplantation	31026
transections	31026
transplantation	31052
Assessment of hindlimb motor	31069
Assessment	31069
hindlimb motor	31083
transplantation	31116
Hindlimb motor function	31132
the BBB scale	31175
the third day post-surgery	31202
weekly intervals starting on day 7	31236
weekly intervals	31236
day 7	31265
The experimental plan	31272
hindlimb motor function	31308
4 weeks	31347
transplantation	31376
transplantation based on the BBB scores	31421
transplantation	31421
the BBB scores	31446
deficits of the groups that would receive OLP vs. RLP transplants	31476
deficits	31476
the groups that would receive OLP vs. RLP transplants	31488
the groups	31488
OLP vs. RLP transplants	31518
OLP	31518
RLP transplants	31526
the BBB scores at 4 weeks postinjury	31552
the BBB scores	31552
4 weeks postinjury	31570
fifteen animals	31590
the study	31627
they	31645
BBB scores	31654
2	31678
attrition	31693
death and exclusion based on BBB scores , at 4 weeks post-injury	31710
death and exclusion	31710
BBB scores	31739
4 weeks	31754
a total of 14 animals with complete transections	31775
a total	31775
14 animals with complete transections	31786
14 animals	31786
complete transections	31802
inclusion in the study -LRB- BBB scores 2 or less -RRB-	31857
inclusion	31857
the study -LRB- BBB scores 2 or less -RRB-	31870
the study	31870
BBB scores 2 or less	31881
BBB	31881
scores 2 or less	31885
scores	31885
2 or less	31892
One animal	31904
a result of anesthetic complications	31923
a result	31923
anesthetic complications	31935
preparation for transplantation	31967
preparation	31967
transplantation	31983
The remaining 13 animals	32000
either OLP or RLP	32048
OLP	32055
RLP	32062
Six animals	32067
OLP tissue and seven	32088
OLP tissue	32088
seven	32103
RLP tissue transplants	32118
Animal attrition	32142
transplantation surgery	32169
the 10-week period	32200
transplantation , 1 rat that had received an OLP transplant	32229
transplantation	32229
1 rat that had received an OLP transplant	32246
1 rat	32246
an OLP transplant	32270
post-transplantation day	32306
20	32331
The animal	32335
signs of complications in the days	32364
signs	32364
complications in the days	32373
complications	32373
the days	32390
the sudden death	32408
the cause of death	32430
the cause	32430
death	32443
Two rats that received OLP transplants	32470
Two rats	32470
OLP transplants	32493
autophagia	32526
the transplantation surgery	32543
BBB scores for these 3 animals	32572
BBB scores	32572
these 3 animals	32587
the time of death/euthanasia	32625
the time	32625
death/euthanasia	32637
attrition due to all causes	32667
attrition	32667
all causes	32684
only 3 animals in the OLP group	32696
only 3 animals	32696
the OLP group	32714
the BBB scale	32752
the entire survival period	32770
the target group size to match Lu et al. was n = 6	32798
the target group size	32798
Lu	32829
et al. was n = 6	32832
et al.	32832
n = 6	32843
n	32843
6	32847
Attrition	32851
the RLP group	32873
the total number of animals available for BBB analysis	32892
the total number	32892
animals available for BBB analysis	32912
animals	32912
BBB analysis	32934
n = 6 , which was in fact at the target group size to replicate Lu et al.	32951
n	32951
6	32955
fact at the target group size	32971
fact	32971
the target group size	32979
Lu	33014
et al.	33017
One rat in the RLP group	33024
One rat	33024
the RLP group	33035
autophagia	33059
day 69	33073
BBB scores	33085
the onset of autophagia	33105
the onset	33105
autophagia	33118
Assessment of hindlimb motor function after transplantation Fig. 6	33143
Assessment	33143
hindlimb motor function after transplantation Fig. 6	33157
hindlimb motor function	33157
transplantation Fig. 6	33187
average BBB scores	33222
the postinjury survival interval for the OLP and RLP groups	33248
the postinjury survival interval	33248
the OLP and RLP groups	33285
Arrows	33309
the days that animals either died or became un-testable	33325
the days	33325
foot autophagia	33393
There	33410
no difference in average BBB scores	33420
no difference	33420
average BBB scores	33437
transplantation	33465
transplantation	33488
there	33505
no significant improvement	33515
BBB scores in either group	33545
BBB scores	33545
either group	33559
no significant difference	33576
the average BBB scores for the groups at any time point	33610
the average BBB scores	33610
the groups at any time point	33637
the groups	33637
any time point	33651
BBB scores	33667
transplantation	33687
day 27 for the group that received OLP transplant were 0.17 ± 0.12	33706
day 27	33706
the group that received OLP transplant were 0.17 ± 0.12	33717
the group	33717
OLP transplant	33741
0.17 ± 0.12	33761
0.17	33761
0.12	33768
the group that received RLP transplant	33781
the group	33781
RLP transplant	33805
0.29 ± 0.16 -LRB- mean ± SEM -RRB-	33825
0.29 ± 0.16	33825
0.29	33825
0.16	33832
SEM	33845
Post-transplantation scores	33851
day 106 for the group with OLP transplant	33882
day 106	33882
the group with OLP transplant	33894
the group	33894
OLP transplant	33909
0.25 ± 0.29	33929
0.25	33929
0.29	33936
the group with RLP transplants	33949
the group	33949
RLP transplants	33964
0.92 ± 0.09	33985
0.92	33985
0.09	33992
SEM	34005
Bladder assessment Assessment of urine volumes	34011
Bladder assessment Assessment	34011
urine volumes	34044
rats	34072
higher	34086
normal volumes of urine	34098
normal volumes	34098
urine	34116
the initial 10-day period following transection -LRB- Fig. 7 -RRB-	34129
the initial 10-day period	34129
transection -LRB- Fig. 7 -RRB-	34165
transection	34165
Fig. 7	34178
Urine volumes	34187
normal levels	34223
bladder function	34240
There	34275
no change	34285
the amount	34298
urine	34321
the transplantation surgery	34333
either OLP or RLP group	34364
OLP	34371
RLP group	34378
there	34393
no statistically significant difference between the two groups	34403
no statistically significant difference	34403
the two groups	34451
Morphology and histology of the lesion sites Fig. 8	34467
Morphology and histology	34467
the lesion sites Fig. 8	34495
the lesion sites Fig.	34495
8	34517
images	34531
spinal cords	34541
animals in Experiment 1	34559
animals	34559
Experiment 1	34570
OLP or RLP transplants	34597
the two principal experimental groups	34655
the time of dissection	34697
the time	34697
dissection	34709
we	34721
adherent scar tissue	34750
adherent scar tissue	34779
the lesion / transplant site in Fig. 8	34815
the lesion	34815
transplant site in Fig. 8	34827
transplant site	34827
Fig. 8	34846
All five animals in the OLP transplant group	34854
All five animals	34854
the OLP transplant group	34874
only 3 of these	34936
only 3	34936
these	34946
the entire post-operative period	34972
rats # 12 and 28	35006
rats # 12	35006
rats	35006
28	35019
BBB for the entire assessment period	35045
BBB	35045
the entire assessment period	35053
autophagia of the hind feet	35089
autophagia	35089
the hind feet	35103
Data from these animals	35118
Data	35118
these animals	35128
the analysis	35159
the onset of autophagia	35178
the onset	35178
autophagia	35191
all animals	35206
the transection cavity	35219
tissue	35258
survival of the transplants	35277
survival	35277
the transplants	35289
Hoechst labeling and H&E staining .	35306
Hoechst	35306
labeling and H&E staining	35314
Histological evaluation of the spinal cords from Experiment 1	35341
Histological evaluation	35341
the spinal cords from Experiment 1	35368
the spinal cords	35368
Experiment 1	35390
tissue	35412
the lesion sites	35430
all cases	35450
the transplants	35483
the most part	35520
the gap between rostral and caudal segments -LRB- Figs. 9 and 10 -RRB-	35543
the gap	35543
rostral and caudal segments -LRB- Figs. 9 and 10 -RRB-	35559
rostral and caudal segments	35559
Figs. 9 and 10	35588
Figs. 9	35588
10	35600
Hoechst-labeled cells	35605
the transplant tissue	35643
Hoechst-labeled nuclei	35670
the spinal cord rostral and caudal	35714
the spinal cord rostral	35714
caudal	35742
the transplant -LRB- Fig. 9 -RRB-	35752
the transplant	35752
Fig. 9	35768
The Hoechst-labeled nuclei in regions outside the transplant	35777
The Hoechst-labeled nuclei	35777
regions outside the transplant	35807
regions	35807
the transplant	35823
migration	35852
cells	35873
the host tissue or diffusion of the label	35884
the host tissue or diffusion	35884
the label	35916
the living animal or the tissue block	35933
the living animal	35933
the tissue block	35954
It	35972
the level of fluorescence	35995
the level	35995
fluorescence	36008
distance	36050
the transplant	36064
much if not all of the labeling outside the transplant proper	36096
much	36096
all of the labeling outside the transplant proper	36108
all	36108
the labeling outside the transplant proper	36115
the labeling	36115
the transplant proper	36136
a result of diffusion of the bisbenzimide	36162
a result	36162
diffusion of the bisbenzimide	36174
diffusion	36174
the bisbenzimide	36187
migration of Hoechstlabeled cells	36216
migration	36216
Hoechstlabeled cells	36229
the cells within the transplant	36291
the cells	36291
the transplant	36308
the photomicrographs of the Hoechst labeling	36338
the photomicrographs	36338
the Hoechst labeling	36362
the same sections	36384
H&E -LRB- Fig. 10 -RRB-	36419
H&E	36419
Fig. 10	36424
The H&E	36434
sections	36450
OLP and RLP transplants	36473
a complex and distinct cellular organization	36507
a complex	36507
distinct cellular organization	36521
neither	36556
OLP or RLP transplants	36564
there any indication	36591
there	36591
any indication	36597
ongoing inflammatory cell invasion	36615
example perivascular cuffing of inflammatory cells	36655
example perivascular cuffing	36655
inflammatory cells	36687
chronic inflammation that would suggest an ongoing tissue rejection process	36710
chronic inflammation	36710
an ongoing tissue rejection process	36750
Experiment 2 The lack	36787
Experiment 2	36787
The lack	36800
effect of OLP transplants on locomotor function in Experiment 1	36812
effect	36812
OLP transplants on locomotor function in Experiment 1	36822
OLP transplants	36822
locomotor function in Experiment 1	36841
locomotor function	36841
Experiment 1	36863
striking contrast to the results of Lu	36882
striking contrast	36882
the results of Lu	36903
the results	36903
Lu	36918
et al. -LRB- 2002 -RRB-	36921
et al.	36921
2002	36929
the number	36950
animals that could be tested for the entire period in the OLP group	36964
animals	36964
the entire period in the OLP group	36997
the entire period	36997
the OLP group	37018
the conclusion tentative	37037
we	37074
a second replication using a modified surgical procedure	37089
a second replication	37089
a modified surgical procedure	37116
Materials and methods	37151
Materials	37151
methods	37165
a plan	37183
aggressive treatment of early signs of autophagia	37194
aggressive treatment	37194
early signs of autophagia	37218
early signs	37218
autophagia	37233
One additional modification	37245
an increase	37277
the amount	37292
fluids given to prevent dehydration immediately after the transection surgeries	37306
fluids	37306
dehydration	37330
the transection surgeries	37360
Experiment 2	37390
all rats	37404
the first 4 weeks	37426
transection surgery	37454
none	37479
autophagia	37494
Assessment	37506
hindlimb motor function prior to transplantation Hindlimb motor function	37520
hindlimb motor function	37520
transplantation	37553
Hindlimb motor function	37569
Hindlimb	37569
motor function	37578
the BBB scale	37612
the first day post-surgery and at weekly intervals	37639
the first day	37639
weekly intervals	37673
Eight of the ten animals	37702
Eight	37702
the ten animals	37711
BBB scores	37737
the range of 0 -- 1 during this initial post-injury testing period	37751
the range	37751
0 -- 1 during this initial post-injury testing period	37764
0 -- 1	37764
this initial post-injury testing period	37775
a complete transection injury	37832
Two animals	37863
BBB scores	37885
2 at 2 weeks	37908
further testing	37961
Fig. 11	37978
the BBB scores	37998
the 8 animals that were eligible for continuation in the study	38018
the 8 animals	38018
continuation	38055
the study	38071
Five of the eight animals	38082
Five	38082
the eight animals	38090
OLP transplants	38117
this	38141
the critical group	38150
3	38170
RLP transplants	38181
One rat in the RLP group	38198
One rat	38198
the RLP group	38209
4 weeks	38228
transplantation	38242
kidney failure	38265
the completion of Experiment 2	38290
the completion	38290
Experiment 2	38308
there	38322
two animals in the RLP group and five animals in the OLP group	38333
two animals in the RLP group	38333
two animals	38333
the RLP group	38348
five animals in the OLP group	38366
five animals	38366
the OLP group	38382
The total number of animals from both Experiment 1 and 2	38397
The total number	38397
animals from both Experiment 1 and 2	38417
animals	38417
both Experiment 1 and 2	38430
n	38458
8	38462
the OLP group -LRB- Experiment 1 , n = 3 and Experiment 2 , n = 5 -RRB-	38467
the OLP group	38467
Experiment 1 , n = 3 and Experiment 2 , n = 5	38482
Experiment 1	38482
n = 3	38496
n	38496
3	38500
Experiment 2 , n = 5	38506
Experiment 2	38506
n = 5	38520
n	38520
5	38524
n	38531
8	38535
the RLP group -LRB- Experiment 1 , n = 6 and Experiment 2 , n = 2 -RRB-	38540
the RLP group	38540
Experiment 1 , n = 6 and Experiment 2 , n = 2	38555
Experiment 1	38555
n = 6	38569
n	38569
6	38573
Experiment 2 , n = 2	38579
Experiment 2	38579
n = 2	38593
n	38593
2	38597
the numbers	38624
the original Lu	38639
et al. study OLP -LRB- n = 6 -RRB- and RLP -LRB- n = 7 -RRB-	38655
et al. study OLP -LRB- n = 6 -RRB-	38655
et al. study OLP	38655
n	38673
6	38677
RLP -LRB- n = 7 -RRB-	38684
RLP	38684
n	38689
7	38693
Assessment of hindlimb motor function	38697
Assessment	38697
hindlimb motor function	38711
transplantation	38741
Experiment 1	38763
hindlimb motor function	38777
the BBB scale	38820
weekly intervals	38837
the transplantation surgery -LRB- see Fig. 11 -RRB-	38860
the transplantation surgery	38860
Fig. 11	38893
the results from Experiment 1	38919
the results	38919
Experiment 1	38936
there	38950
no significant improvement	38960
BBB scores after transplantation	38990
BBB scores	38990
transplantation	39007
no difference between the average BBB scores of the rats	39027
no difference	39027
the average BBB scores of the rats	39049
the average BBB scores	39049
the rats	39075
OLP vs. RLP transplants	39098
OLP	39098
RLP transplants	39106
any time point	39125
Morphology and histology of the lesion sites Fig. 12	39141
Morphology and histology	39141
the lesion sites Fig. 12	39169
the lesion sites Fig.	39169
12	39191
images of spinal cords	39206
images	39206
spinal cords	39216
animals that received OLP and RLP transplants respectively in Experiment 2	39234
animals	39234
OLP and RLP transplants	39256
Experiment 2	39296
Fig. 13	39314
sections	39346
representative cases	39360
Experiment 1	39388
transplant tissue	39402
the lesion site	39435
all animals	39454
sections	39479
transplant tissue	39497
the lesion site	39526
substantial tissue continuity between rostral	39548
substantial tissue continuity	39548
rostral	39586
caudal segments in many animals -LRB- Fig. 13 -RRB-	39598
caudal segments	39598
many animals -LRB- Fig. 13 -RRB-	39617
many animals	39617
Fig. 13	39631
Bridging	39641
other animals	39671
some animals	39690
large cavities and thinner tissue bridges	39713
large cavities	39713
thinner tissue bridges	39732
these examples	39768
Experiment 1	39790
OLP transplants	39804
a complex cellular organization -LRB- Fig. 13C -RRB-	39830
a complex cellular organization	39830
Fig. 13C	39863
no indication	39879
acute inflammation suggestive of an ongoing tissue rejection process	39896
acute inflammation suggestive	39896
an ongoing tissue rejection process	39929
The section shown in Fig. 13C	39966
The section	39966
Fig. 13C	39987
nearby	39999
75 μm	40014
the section illustrated in Fig. 16 stained for 5HT	40024
the section	40024
Fig. 16 stained for 5HT	40051
Fig. 16	40051
5HT	40071
results of Experiments 1 and 2	40085
results	40085
Experiments 1 and 2	40096
Fig. 14	40134
the combined data from Experiment 1 and 2	40143
the combined data	40143
Experiment 1 and 2	40166
Experiment 1	40166
2	40183
there	40200
no significant improvement	40210
BBB scores	40240
the OLP group after transplantation	40254
the OLP group	40254
transplantation	40274
no significant difference between the average BBB scores of OLP and RLP groups	40294
no significant difference	40294
the average BBB scores of OLP and RLP groups	40328
the average BBB scores	40328
OLP and RLP groups	40354
any time point	40376
None of the animals in either transplant group	40392
None	40392
the animals	40400
transplant group	40422
any significant movement	40449
hindlimb motor function	40477
This	40502
contrast	40513
the report	40525
Lu et al. -LRB- 2002 -RRB-	40539
Lu	40539
et al. -LRB- 2002 -RRB-	40542
et al.	40542
2002	40550
rats that received OLP transplants	40566
rats	40566
OLP transplants	40585
hindlimb motor function	40618
the transplants	40648
a slow improvement	40678
function	40700
the testing interval	40714
All rats from both experiments	40756
All rats	40756
both experiments	40770
Fluorogold injections	40796
the lumbar enlargement caudal	40823
the injury site	40856
3 days	40872
they	40886
order	40906
neurons	40922
the brain that had regenerated past the lesion site	40933
the brain	40933
the lesion site	40969
Similar injections	40986
3 non-injured control rats	41020
the cell groups	41059
the brain that normally project to the lumbar enlargement	41086
the brain	41086
project	41110
the lumbar enlargement	41121
non-injured control animals that received Fluorogold injections	41148
non-injured control animals	41148
Fluorogold injections	41190
FG-labeled neurons	41213
multiple brainstem nuclei	41248
the spinal cord	41290
the red nucleus	41317
vestibular nuclei	41334
locus coeruleus	41353
raphe nuclei	41370
reticular formation	41388
Fig. 15A	41409
FG-labeled neurons	41420
the sensorimotor cortex	41472
various nuclei of the hypothalamus -LRB- data not shown -RRB-	41503
various nuclei	41503
the hypothalamus	41521
data not shown	41539
data	41539
No retrogradely labeled cells	41556
No retrogradely	41556
cells	41580
any rats	41599
OLP or RLP transplants	41629
Fig. 15B	41662
Immunostaining for serotonin -LRB- 5HT -RRB- Serotonin -LRB- 5HT -RRB-	41673
Immunostaining	41673
serotonin -LRB- 5HT -RRB- Serotonin -LRB- 5HT -RRB-	41692
serotonin -LRB- 5HT -RRB- Serotonin	41692
serotonin -LRB- 5HT -RRB-	41692
serotonin	41692
5HT	41703
5HT	41719
fibers	41735
brain stem nuclei , especially the raphe nuclei , and project	41755
brain stem nuclei	41755
especially the raphe nuclei	41774
project	41807
the longitudinal extent of the spinal cord	41826
the longitudinal extent	41826
the spinal cord	41853
These fibers	41870
a somewhat greater growth capacity following spinal cord injury	41903
a somewhat greater growth capacity	41903
spinal cord injury	41948
immunostaining	42003
cross-sections through the spinal cord above and below the lesion site	42032
cross-sections	42032
the spinal cord above and below the lesion site	42055
the spinal cord	42055
the lesion site	42087
one section	42108
every three	42123
the series of sagittal sections through the lesion and transplant site	42138
the series	42138
sagittal sections through the lesion and transplant site	42152
sagittal sections	42152
the lesion and transplant site	42178
5HT	42233
5HT immunoreactive fibers	42238
the gray and white matter of cross-sections	42280
the gray and white matter	42280
cross-sections	42309
rostral segments of the spinal cord in the rostral sections in all animals	42332
rostral segments	42332
the spinal cord in the rostral sections in all animals	42352
the spinal cord	42352
the rostral sections in all animals	42371
the rostral sections	42371
all animals	42395
Fig. 16A	42408
the pattern of labeling in rostral segments	42429
the pattern	42429
labeling in rostral segments	42444
labeling	42444
rostral segments	42456
a representative animal	42478
most animals	42506
no 5HT-labeled axons	42520
caudal segments	42554
two animals	42583
OLP transplants and one that received an RLP transplant	42609
OLP transplants	42609
one that received an RLP transplant	42629
one	42629
an RLP transplant	42647
a very small number of 5HT-labeled axons	42666
a very small number	42666
5HT-labeled axons	42689
segments caudal to the injury -LRB- Fig. 16B -RRB-	42720
segments	42720
the injury -LRB- Fig. 16B -RRB-	42739
the injury	42739
Fig. 16B	42751
The case that exhibited the largest number of 5HT axons in caudal segments	42762
The case	42762
the largest number of 5HT axons	42786
the largest number	42786
5HT axons	42808
caudal segments	42821
an animal that had received an RLP transplant -LRB- Figs. 16B and C -RRB-	42841
an animal	42841
an RLP transplant -LRB- Figs. 16B and C -RRB-	42869
an RLP transplant	42869
Figs. 16B and C	42888
Figs. 16B	42888
C	42902
the two animals	42909
OLP transplants in which 5HT fibers were seen caudal to the lesion , only 2	42939
OLP transplants	42939
5HT fibers	42964
the lesion , only 2	42995
the lesion	42995
only 2	43007
4 5HTlabeled axons	43014
cross-section -LRB- Fig. 16D -RRB-	43047
cross-section	43047
Fig. 16D	43062
the axons	43092
rise	43119
small terminal arbors -LRB- Fig. 16H -RRB-	43127
small terminal arbors	43127
Fig. 16H	43150
Examination of sagittal sections through the lesion	43161
Examination	43161
sagittal sections	43176
the lesion	43202
transplant site	43214
5HT-labeled axons	43244
the boundary of the lesion -LRB- Figs. 16E -- G -RRB-	43286
the boundary	43286
the lesion -LRB- Figs. 16E -- G -RRB-	43302
the lesion	43302
Figs. 16E -- G	43314
Figs. 16E	43314
G	43324
the most caudally located axons	43335
tortuous varicosities suggesting sprouting -LRB- Fig. 16F -RRB-	43377
tortuous varicosities	43377
Fig. 16F	43421
most animals	43435
few if any 5HT-labeled axons	43449
the transplant	43497
itself	43512
the animals in which 5HT axons were seen in caudal segments	43537
the animals	43537
5HT axons	43558
caudal segments	43581
5HT axons	43598
the transplant	43631
rostral segments -LRB- Figs. 16F and G -RRB-	43651
rostral segments	43651
Figs. 16F and G	43669
Figs. 16F	43669
G	43683
5HT-positive axons	43696
the transplant	43738
none	43754
the caudal segments	43780
Discussion	43802
The present study	43813
the experiments	43840
Lu	43868
et al. -LRB- 2002 -RRB- in order	43871
et al. -LRB- 2002 -RRB-	43871
et al.	43871
2002	43879
order	43888
the reproducibility and robustness	43904
the enhanced recovery of motor function seen after OLP transplants	43942
the enhanced recovery	43942
motor function seen after OLP transplants	43967
motor function	43967
OLP transplants	43993
1 month	44014
a complete transection of the spinal cord	44028
a complete transection	44028
the spinal cord	44054
the low thoracic level	44073
Our results	44097
no hint of improved function	44118
no hint	44118
improved function	44129
OLP transplantation	44153
any significant difference	44176
hindlimb motor function	44206
rats that received OLP vs. RLP transplants in either of the two experiments	44238
rats	44238
OLP vs. RLP transplants	44257
OLP	44257
RLP transplants	44265
either of the two experiments	44284
either	44284
the two experiments	44294
the data from the two experiments combined	44320
the data	44320
the two experiments combined	44334
the two experiments	44334
The failure to observe a positive effect of the OLP transplants	44364
a positive effect of the OLP transplants	44387
a positive effect	44387
the OLP transplants	44408
a number of technical issues	44444
a number	44444
technical issues	44456
any case	44502
our results	44512
the view	44539
OLP transplants	44553
a robust and reproducible effect	44574
the setting of a complete spinal cord transection injury	44610
the setting	44610
a complete spinal cord transection injury	44625
there	44677
evidence	44687
both types of transplants	44701
both types	44701
transplants	44715
limited regeneration of 5HT axons	44737
limited regeneration	44737
5HT axons	44761
some animals	44774
Experiment 1	44791
a significant number of animals	44805
a significant number	44805
animals	44829
severe autophagia	44847
the group that received OLP transplants	44880
the group	44880
OLP transplants	44904
It	44921
other studies	44943
an increased incidence	44973
autophagia	44999
animals	45013
transplants that included olfactory ensheathing cells	45035
transplants	45035
olfactory ensheathing cells	45061
Richter	45090
et al. , 2005	45098
et al.	45098
2005	45106
Experiment 2	45116
none of the animals	45130
none	45130
the animals	45138
autophagia following the transection or following transplantation surgeries	45160
autophagia	45160
the transection or following transplantation surgeries	45181
the transection	45181
following transplantation surgeries	45200
Differences	45237
Experiments 1 and 2	45257
the absence of autophagia	45307
the absence	45307
autophagia	45322
Experiment 2	45336
differences in the age of the rats	45357
differences	45357
the age of the rats	45372
the age	45372
the rats	45383
the time of the transection	45395
the time	45395
the transection	45407
slight differences in surgical procedure	45424
slight differences	45424
surgical procedure	45446
a minor change in post-operative care	45470
a minor change	45470
post-operative care	45488
the amount of saline delivered to prevent dehydration	45520
the amount	45520
saline delivered to prevent dehydration	45534
saline	45534
dehydration	45562
Materials and methods	45588
Materials	45588
methods	45602
we	45611
the surgical procedure	45623
Experiments 1 and 2	45663
the high incidence of incomplete lesions	45694
the high incidence	45694
incomplete lesions	45716
Experiment 1	45738
This	45752
a reflection of the fact	45760
a reflection	45760
the fact	45776
spinal cord tissue	45790
one	45845
a blade across the spinal cord	45863
a blade	45863
the spinal cord	45878
The modification	45895
Experiment 2	45915
a curved needle	45952
the spinal cord	45974
it	46002
more consistent lesions	46022
the spinal cord	46055
only elevated	46075
1 -- 2 mm	46098
1	46098
2 mm	46100
there	46106
and no evidence of any contusion injury	46135
no evidence of any contusion injury	46139
no evidence	46139
any contusion injury	46154
The total numbers of animals in the combined groups	46176
The total numbers	46176
animals in the combined groups	46197
animals	46197
the combined groups	46208
the number analyzed in the previous report by Lu et al.	46247
the number	46247
the previous report	46270
Lu et al.	46293
Lu	46293
et al.	46296
the numbers in both the original study and the present one	46312
the numbers	46312
both the original study and the present one	46327
the original study	46332
the present one	46355
it	46392
a lack of sufficient statistical power	46412
a lack	46412
sufficient statistical power	46422
the failure	46465
a positive effect of OLP transplants	46487
a positive effect	46487
OLP transplants	46508
the present study	46527
there	46553
no improvement in hindlimb motor function	46574
no improvement	46574
hindlimb motor function	46592
the OLP transplants and the BBB scores from the two groups	46622
the OLP transplants	46622
the BBB scores from the two groups	46646
the BBB scores	46646
the two groups	46666
There	46704
procedural issues	46715
note regarding the lack of effect of OLP transplants in the present experiment	46752
note	46752
the lack of effect of OLP transplants in the present experiment	46767
the lack	46767
effect of OLP transplants in the present experiment	46779
effect	46779
OLP transplants in the present experiment	46789
OLP transplants	46789
the present experiment	46808
the rats used by Lu et al.	46839
the rats	46839
Lu	46856
et al.	46859
their local institutional breeding colony	46876
the rats in the present study	46927
the rats	46927
the present study	46939
commercial sources	46967
discussions with the original authors	46990
discussions	46990
the original authors	47007
the point	47029
there	47055
less genetic diversity in the local colony due to inbreeding	47075
less genetic diversity	47075
the local colony due to inbreeding	47101
the local colony	47101
inbreeding	47125
rejection of the transplant	47145
rejection	47145
the transplant	47158
an issue.We	47182
the possibility of treating animals with immunosuppressants	47205
the possibility	47205
animals	47233
immunosuppressants	47246
the decision	47274
this	47292
a significant departure from the original experiment	47306
a significant departure	47306
the original experiment	47335
immunosuppressants	47379
outcome following spinal cord injury -LRB- Ibarra et al. , 2003 -RRB-	47408
outcome	47408
spinal cord injury -LRB- Ibarra et al. , 2003 -RRB-	47426
spinal cord injury	47426
Ibarra	47446
et al. , 2003	47453
et al.	47453
2003	47461
Histological assessment	47468
transplant tissue	47506
there	47541
no obvious evidence for chronic inflammation or rejection	47551
no obvious evidence	47551
chronic inflammation or rejection	47575
the time the animals were killed	47612
the time	47612
the animals	47621
We	47646
the possibility	47664
certain cell types within the transplant -LRB- especially OECs -RRB-	47695
certain cell types	47695
the transplant -LRB- especially OECs -RRB-	47721
the transplant	47721
OECs	47748
rejection	47788
It	47799
a greater degree of tissue mismatch	47824
a greater degree	47824
tissue mismatch	47844
a greater encapsulation of the transplanted tissue in the present experiment	47867
a greater encapsulation	47867
the transplanted tissue in the present experiment	47894
the transplanted tissue	47894
the present experiment	47921
the experiment	47952
Lu et al.	47970
Lu	47970
et al.	47973
Previous studies	47980
solid tissue transplants	48013
a separate entity	48056
graft -- host re-innervation -LRB- Fisher and Gage , 1993 -RRB-	48094
graft	48094
host re-innervation -LRB- Fisher and Gage , 1993 -RRB-	48100
host re-innervation	48100
Fisher and Gage	48121
1993	48138
transplant tissue	48165
solid tissues -LRB- Lu et al. , 2001 -RRB-	48233
solid tissues	48233
Lu	48248
et al. , 2001	48251
et al.	48251
2001	48259
there	48269
a greater encapsulation of the transplanted tissue in the present experiments	48279
a greater encapsulation	48279
the transplanted tissue in the present experiments	48306
the transplanted tissue	48306
the present experiments	48333
this	48358
effective regeneration	48382
there	48422
the histological preparations	48451
encapsulation	48492
any unusual tissue barrier between the transplant and the host tissue	48509
any unusual tissue barrier	48509
the transplant and the host tissue	48544
the transplant	48544
the host tissue	48563
It	48580
the orientation	48605
the lamina of the OLP tissue that was transplanted into the lesion area	48624
the lamina	48624
the OLP tissue that was transplanted into the lesion area	48638
the OLP tissue	48638
the lesion area	48680
regeneration	48725
Lu et al.	48739
Lu	48739
et al.	48742
this issue	48765
any special attempt	48796
the transplanted tissue	48826
it	48865
chance	48889
their procedures	48897
an orientation	48921
the transplanted tissue	48939
a favorable setting	48976
regeneration	49010
our procedures	49031
terms of transplant survival	49058
terms	49058
transplant survival	49067
one technical issue worthy of mention	49088
one technical issue	49088
mention	49118
bisbenzimide	49152
a valid marker for the transplanted tissue	49191
a valid marker	49191
the transplanted tissue	49210
the transplant	49248
Hoechst	49299
there	49312
large numbers	49328
fluorescent nuclei in the intact parenchyma on each side of the transplant	49345
fluorescent nuclei	49345
the intact parenchyma on each side of the transplant	49367
the intact parenchyma	49367
each side of the transplant	49392
each side	49392
the transplant	49405
the intensity of fluorescence	49434
the intensity	49434
fluorescence	49451
a gradient	49478
distance	49494
the transplant	49508
This	49524
diffusion of the label	49548
diffusion	49548
the label	49561
the living spinal	49582
histological preparation	49609
not the pattern	49642
labeling	49661
cells	49704
the transplant	49729
One other technical issue that is worthy of mention	49745
One other technical issue	49745
mention	49789
our practice	49800
bladders	49827
at least 10 min	49836
BBB testing	49861
spastic movements of the hindlimbs related to bladder fullness	49900
spastic movements	49900
the hindlimbs related to bladder fullness	49921
the hindlimbs	49921
bladder fullness	49946
It	49964
at least 10 min	50000
bladder expression before BBB testing	50022
bladder expression	50022
BBB testing	50048
animals	50068
spastic movements	50089
bladder expression	50129
Lu	50149
et al. also expressed bladders prior to BBB testing in their experiments	50152
et al.	50152
bladders	50174
BBB testing	50192
their experiments	50207
P. Waite , personal communication	50226
P.	50226
Waite	50229
personal communication	50236
it	50267
the hindlimb movements	50287
their rats that received OLP transplants were related to bladder fullness	50323
their rats	50323
OLP transplants	50348
bladder fullness	50380
It	50398
the time between bladder expression and BBB testing	50433
the time	50433
bladder expression and BBB testing	50450
bladder expression	50450
BBB testing	50473
the two studies	50497
the reason	50523
any evidence	50558
enhanced motor function or axon regeneration following OLP transplants	50574
enhanced motor function or axon regeneration	50574
OLP transplants	50629
the approach	50660
limited regeneration	50687
some circumstances	50714
the effect	50738
the hostile setting created by a complete transection paradigm	50790
the hostile setting	50790
a complete transection paradigm	50821
This	50854
evidence against the idea	50892
evidence	50892
the idea	50909
olfactory ensheathing cells in general	50923
olfactory ensheathing cells	50923
general	50954
CNS axon regeneration under other circumstances	50976
CNS axon regeneration	50976
other circumstances	51004
experiments in which the experimental lesions are more limited	51036
experiments	51036
the experimental lesions	51057
the hostility of the tissue environment	51116
the hostility	51116
the tissue environment	51133
transplants of olfactory ensheathing cells	51158
transplants	51158
olfactory ensheathing cells	51173
a profound stimulatory or at least supportive effect	51228
axon regeneration	51284
example Li et al. , 1997 , 1998	51311
example Li et al.	51311
example Li	51311
et al.	51322
1997 , 1998	51330
1997	51330
1998	51336
